Premium
Lipid Metabolism, Epidemiology, and the Mechanisms of Alzheimer's Disease
Author(s) -
FRIEDLAND ROBERT P.
Publication year - 2002
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/j.1749-6632.2002.tb04842.x
Subject(s) - antibody , disease , endocrinology , transthyretin , medicine , genetically modified mouse , apolipoprotein b , lipid metabolism , alzheimer's disease , cholesterol , biology , immunology , physiology , transgene , biochemistry , gene
A bstract : Global variations in the incidence and prevalence of Alzheimer's disease (AD) have not been explained. Patterns of dietary intake of fats and other nutrients may be partly responsible. Recent work with transgenic mice overexpressing the β‐amyloid precursor protein suggests that anti‐Aβ antibodies enhance clearance of the Aβ protein from the brain and reduce plaque burden. This has been shown even with anti‐Aβ antibodies that do not enter the brain. Many factors other than circulating anti‐Aβ antibodies may influence this important process of Aβ clearance, including the Aβ‐binding elements, apolipoproteins E and J, circulating LDL, HDL, and LRP, alpha‐2‐macroglobulin, and transthyretin. Also important may be clearance of antibody‐antigen complexes from the circulation, as well as complement, metals, and estrogen. Dietary intake of lipids may influence the ability of Aβ‐binding proteins to enhance clearance of Aβ from the brain to blood. Understanding processes of Aβ clearance from brain may aid in determining the causes of AD in individuals, as well as the causes of global variations in incidence and prevalence of the disease.